Severe hyperthermia after acute cessation of continuous intrathecal baclofen administration;Hyperthermie grave liee a un sevrage brutal de baclofene administre de facon continue par voie intrathecale

Annales Francaises d'Anesthesie et de Reanimation

Volumn 15, Issue 5, 1996, Pages 659-662

  Grenier, B ^a   Mesli, A ^a   Cales, J ^a   Castel, J P ^b   Maurette, P ^a  

^a Dept d'Anesthesie Reanimation 3 ^*  (France)

^b HÔPITAL PELLEGRIN   (France)

Author keywords

baclofen; hyperthermia; rhabdomyolysis; withdrawal syndrome

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BACLOFEN; CENTRAL MUSCLE RELAXANT;

ADULT; ANESTHESIA COMPLICATION; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; HUMAN; HYPERTHERMIA; MALE; MUSCLE HYPERTONIA; MYOGLOBINURIA; RHABDOMYOLYSIS; SPASTICITY; CHEMICALLY INDUCED DISORDER; FEVER; INFUSION PUMP; INTRASPINAL DRUG ADMINISTRATION; MUSCLE HYPOTONIA; WITHDRAWAL SYNDROME;

ADULT; BACLOFEN; FEVER; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MALE; MUSCLE HYPOTONIA; MUSCLE RELAXANTS, CENTRAL; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0030333151     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/0750-7658(96)82130-7     Document Type: Article

References (18)

1. 1 Siegfried RN, Jacobson L, Chabal C. Development of an acute withdrawal syndrome following the cessation of intrathecal baclofen in a patient with spasticity. Anesthesiology 1992;77:1048-50
2. 2 McDowell FH. Treatment of spasticity. Drugs 1981;22:401-8
3. 3 Wuis EW. Spasticity and drug therapy. Pharm Weekbl 1987;9:249-60
4. 4 Garabedian-Ruffalo SM, Ruffalo RL. Adverse effects secondary to baclofen withdrawal. Drug Intell Clin Pharm 1985;19:304-6
5. 5 Abel NA, Smith RA. Intrathecal baclofen for treatment of intractable spinal spasticity. Arch Phys Med Rehabil 1994;75:54-8
6. 6 Muller H. Treatment of severe spasticity: results of a multicenter trial conducted in Germany involving the intrathecal infusion of baclofen by an implantable drug delivery system. Rev Eur Technol Biomed 1991;13:184-6
7. 7 Sahuquillo J, Muxi T, Noguer M, Jodar R, Closa C, Rubio E et al. Intraspinal baclofen in the treatment of severe spasticity and spasms. Acta Neurochir 1991;110:166-73
8. 8 Lazorthes Y, Sallerin-Caute B, Verdie JC, Bastide R, Carillo JP. Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 1990;72:393-402
9. 9 Philippi W, Manon-Espaillat R, Spiegel P, Ruff RL. Clinical and electroencephalographic manifestations of baclofen-induced encephalopathy: review of the literature. Neurology 1990; 40(Suppl 1):134
10. 10 Romijn JA, van Lieshout JJ, Velis DN. Reversible coma due to intrathecal baclofen. Lancet 1986;2:696
11. 11 Harrison SA, Wood CA. Hallucinations after preoperative baclofen discontinuation in spinal cord injury patients. Drug Intell Clin Pharmacol 1985;19:747-9
12. 12 Lee AJ, Clarke CR, Harrison MJ. Hallucinations after withdrawal of baclofen. Lancet 1977;1:858
13. 13 Terrence CF, Fromm GH. Complications of baclofen withdrawal. Arch Neurol 1981;38:588-9
14. 14 Barker I, Grant IS. Convulsions after abrupt withdrawal of baclofen. Lancet 1982;2:556-7
15. 15 Hyser CL, Drake ME. Status epilepticus after baclofen withdrawal. J Natl Med Assoc 1984;76:533-8
16. 16 Mandac BR, Hurvitz EA, Nelson VS. Hyperthermia associated with baclofen withdrawal and increased spasticity. Arch Phys Med Rehabil 1993;74:96-7
17. 17 Bello N, Adnet P, Saulnier F, Lestavel P, Adnet-Bonte C, Reyford H et al. Absence de sensibilité à l'hyperthermie maligne peranesthésique chez 32 patients ayant développé un syndrome malin des neuroleptiques. Ann Fr Anesth Réanim 1994;13:663-8
18. 18 Kozak-Reiss G, Coursange F, Aubert M. Hyperthermies malignes. Encyclop Med Chir 1991;36412E10:1-18